Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors

Class:IdLiteratureReference:9700339
_displayNameCrizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors
_timestamp2020-09-16 05:14:47
author[Person:9700313] Ceccon, Monica
[Person:9699790] Mologni, Luca
[Person:9700352] Bisson, William
[Person:500816] Scapozza, L
[Person:9647075] Gambacorti-Passerini, Carlo
created[InstanceEdit:9700359] Rothfels, Karen, 2020-09-16
journalMol. Cancer Res.
pages122-32
pubMedIdentifier23239810
titleCrizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors
volume11
year2013
(literatureReference)[FailedReaction:9700114] NVP-TAE684-resistant ALK mutants don't bind NVP-TAE684 [Homo sapiens]
[Reaction:9700131] ALK mutants bind type I TKIs [Homo sapiens]
[Reaction:9700184] Ligand-independent dimerization of point mutants of ALK [Homo sapiens]
[Reaction:9700186] Autophosphorylation of point mutants of ALK [Homo sapiens]
[Reaction:9700662] Liganded-ALK dimer binds type I ALK-binding TKIs [Homo sapiens]
[FailedReaction:9715356] brigatinib-resistant ALK mutants don't bind brigatinib [Homo sapiens]
[FailedReaction:9715357] crizotinib-resistant ALK mutants don't bind crizotinib [Homo sapiens]
[Pathway:9717301] NVP-TAE684-resistant ALK mutants [Homo sapiens]
[EntityWithAccessionedSequence:9699828] ALK I1171N [plasma membrane] [Homo sapiens]
[DefinedSet:9700081] NVP-TAE684-sensitive ALK mutants [cytosol] [Homo sapiens]
List all 15 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors (9700339)